| Literature DB >> 30211179 |
Fu Liang Ng1,2, Helen R Warren1, Mark J Caulfield1,2.
Abstract
Hypertension continues to be a major risk factor for global mortality, and recent genome-wide association studies (GWAS) have expanded in size, leading to the identification of further genetic loci influencing blood pressure. In light of the new knowledge from the largest cardiovascular GWAS to date, we review the potential impact of genomics on discovering potential drug targets, risk stratification with genetic risk scores, drug selection with pharmacogenetics, and exploring insights provided by gene-environment interactions.Entities:
Keywords: Hypertension; cardiovascular disease; gene-environment; genetics; pharmacogenetics; risk score
Year: 2018 PMID: 30211179 PMCID: PMC6123211 DOI: 10.21037/atm.2018.06.34
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839